Neil Thornton
Partner Neil practices mainly in biotechnological, pharmaceutical, and chemical patent work. He has particular experience in the fields of immunology, cancer (particularly cancer immunotherapy), neurodegenerative diseases, complement-mediated disorders, age-related macular degeneration, stem cells, gene therapy, inflammation, analgesia, biomarkers, monoclonal antibodies, diagnosis and treatment of infectious diseases, diagnosis and treatment of blood disorders, nucleic acid testing, antimicrobial agents, wound healing and electrochemistry. Neil’s practice involves the drafting, filing and prosecution of patent applications worldwide, the handling of oppositions at the European Patent Office, due diligence work, and advice on freedom to operate and general intellectual property strategy. · Reddie & Grose LLP
About
Neil Thornton is a Partner at Reddie & Grose LLP in England, specialising in biotechnological, pharmaceutical and chemical patent work. He drafts, files and prosecutes patent applications worldwide, handles oppositions at the European Patent Office, undertakes due diligence and advises on freedom to operate and general IP strategy; he joined Reddie & Grose in 1997 and became a partner in 2005.
Practice areas
Office
Expertise
Education
- PhD in Biochemistry (control of gene expression), University of Leicester
- MA in Natural Sciences (specialising in Biochemistry and Molecular Biology), University of Cambridge
Admissions
- European Patent Attorney (2001)
- Chartered Patent Attorney (2002)